Citation Information :
Kumar N, Shankar MM. Practice Changing Continuing Education: A Critical Review of Neurological Complications in Acute Pancreatitis. Journal of Medical Academics 2018; 1 (2):109-110.
This uncommon syndrome of pancreatic encephalopathy was first described in 1923. A manifestation of multiple organ dysfunction syndromes, generally occurs in the early stage of severe acute pancreatitis and carries high mortality of up to 57% and more. The syndrome must be distinguished from Wernicke encephalopathy, which may follow as a part of neurological complications in the last or recovery phase of acute pancreatitis, and occurs as a result of long fasting, hyperemesis and total parenteral nutrition without thiamine. Poorly recognized by clinicians, a large dose of vitamin B1 is effective in the management of Wernicke encephalopathy. In view of above the present review draws attention to the challenging and lesser recognized complications of acute pancreatitis and briefly dwells on their pathogenesis and management.
Zhang XP, Tian H. Pathogenesis of pancreatic encephalopathy in severe acute pancreatitis. Hepatobiliary Pancreat Dis Int 2007;6:134-140.
Rothermich NO, Von Haam E. Pancreatic encephalopathy. J Clin Endocrinol Metab 1941;1:872-881.
Ramanathan RS, Ahluwalia T. Acute necrotizing pancreatitis leading to pancreatic encephalopathy in a patient undergoing long-term continuous ambulatory peritoneal dialysis. J Acad Med Sci 2012;2:85-87.
Lu XS, Qiu F, Li YX, Li JQ, Fan QQ, Zhou RG. Effect of lowermolecular weight heparin in the prevention of pancreatic encephalopathy in the patient with severe acute pancreatitis. Pancreas. 2010 May 1;39(4):516-519.
Yang YL, Li JP, Li KZ, Dou KF. Tumor necrosis factor á antibody prevents brain damage of rats with acute necrotizing pancreatitis. World Journal of Gastroenterology: WJG. 2004 Oct 1;10(19):2898-2900.
Jha RK, Ma Q, Sha H, Palikhe M. Protective effect of resveratrol in severe acute pancreatitis-induced brain injury. Pancreas. 2009 Nov 1;38(8):947-953.